medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 3

<< Back Next >>

salud publica mex 2016; 58 (3)

Maternal-fetal transmission of Trypanosoma cruzi, a health problem slightly studied in Mexico: case Chiapas

Campos-Valdez G, Canseco-Ávila LM, González-Noriega F, Alfaro-Zebadua O, Nava-Medecigo IY, Jiménez-Cardoso E

Language: Spanish
References: 29
Page: 378-384
PDF size: 238.15 Kb.


ABSTRACT

Objective. To determine the Trypanosoma cruzi infection prevalence in 1125 pregnant women and the transmission frequency to their children from Tapachula and Palenque, Chiapas. Materials and methods. We determined the prevalence by serology tests and the transmission frequency by polymerase chain reaction (PCR) and T. cruzi reactivity capacity after 12 months. Results. Total maternal infection prevalence were 23/1 125 (2.04%), 9/600 (1.5%) were from Tapachula and 14/525 (2.6%) from Palenque. The seropositive women were between 20 and 35 years old, 31.8% have Premature Rapture of Membrane and 9.1% have history of perinatal death. The total percentage of positive newborns by PCR was 9/23 (39.13%), out of those 2/9 (22.2%) are from Tapachula and 7/14 (50%) from Palenque. The Maternal Fetal transmission frequency was. 2/9 (22.2%) in Tapachula and 1/14 (7.14%) in Palenque, all positive infants were asynthomatic. Conclusion. The maternal-fetal transmission rate in Chiapas State is variable; the reason could be the maternal immunological status and T. cruzi strain.


REFERENCES

  1. Cusnalder MC, Gómez RD, Amat LI, Aguiló F, Henández A, Laila JM. Chagas Congénito, ¿es posible en España? Ginecología y Obstetricia Clínica 2004;5:198-203.

  2. Sanchez NO, Mora MC, Basombrio MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005;115:668-672. http://doi.org/c6mhr3

  3. Moya P, Basso B, Moretti E. Congenital Chagas disease in Cordoba, Argentina: epidemiological, clinical, diagnostic and therapeutic aspects. Experience of 30 years of follow up. Rev Soc Bras Med Trop 2005;38(Suppl):233-240.

  4. Altcheh J, Biancardi M, Lapeña A, Ballering G, Freilij H. Congenital Chagas disease: experience in the Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. Rev Soc Bras Med Trop 2005;38:41-45.

  5. Brutus L, Schneider D, Postigo J, Delgado W, Mollinedo S, Chippaux JP. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg 2007;101:1159-1160. http://doi. org/bf92tg

  6. Rassi A, Amato NV, Rassi GG, Amato VS, Rossi JA, Luquetti AO, et al. A retrospective search for maternal transmission of Chagas infection from patients in the chronic phase. Rev Soc Bras Med Trop 2004;37:485-489. http://doi.org/dq94wc

  7. Apt W, Zulantay I, Solari A, Ortiz S, Oddo D, Corral G, et al. Vertical transmission of Trypanosoma cruzi in the province of Choapa, IV Region, Chile: preliminary report (2005–2008). Biol Res 2010;43:269-274. http:// doi.org/bs5988

  8. Russomando G, Almirón M, Candia N, Franco L, Sánchez Z, de Guillen I. Implementation and evaluation of a locally sustainable system of prenatal diagnosis to detect cases of congenital Chagas disease in endemic areas of Paraguay. Rev Soc Bras Med Trop 2005;38:49-54.

  9. Sosa ES, Gamboa LMR, Del Cid LJ, Althabe F, Alger J, Almendares O, et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras and México. Am J Trop Med Hyg 2008;79:755-759.

  10. Carabarin LA, González VMC, Rodríguez MO, Baylón PL, Rosales EJL, Reyes LPA, et al. Chagas disease (American trypanosomiasis) in Mexico: an update. Acta Trop 2013;127(2):126-135. http://doi.org/bdwm

  11. Olivera MA, Guillén OF, Cruz VS, Hernández BN, Pérez GE, Córdova CG, et al. Serological and parasitological screening of Trypanosoma cruzi infection in mothers and newborns living in two Chagasic áreas of México. Arch Med Res 2006;37:774-777. http://doi.org/dv3s7r

  12. Guzmán BC, La Huerta S, Velasco CO. Chagas disease. First congenital case report. Arch Med Res 1998;29:195-196.

  13. Jiménez CE, Campos VG, Cortes CA, de la Luz SR, Mendoza CR, Hernández AP, et al. Maternal fetal transmission of Trypanosmoma cruzi: a problem of public health little studied in México. Exp Parasitol 2012;131:425-432. http://doi.org/bdwn

  14. Capurro H, Konichezky S, Fonseca D, Caldeyro BR. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978;93:120-122. http://doi.org/bg8kbp

  15. Kumari S, Sharma M, Yolav M, Sarof A, Kabra M, Mehra R. Trends in neonatal autome with low Apgar Scores. Indian J Pediatr 1993;60(3):415- 422. http://doi.org/b3cxmk

  16. Haynes AB, Regenbogen SE, Weiser TG, Lipsitz SR, Dziekan G, Berry WR, et al. Surgical outcome measurement for a global patient population: Validation of the surgical Apgar Score in 8 countries. Surgery 2011;149:519-524. http://doi.org/bbmsr6

  17. Chippaux JP, Santalla JA, Postigo JR, Romero M, Salas CNA, Schneider D, et al. Sensitivity and specificity of Chagas Stat-Pak® test in Bolivia. Trop Med Int Health 2009;14:732-735. http://doi.org/ddhfqx

  18. da Silveira FJ, Umezawa SE, Luquetti AO. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 2001;17:286-291. http://doi.org/dkzfzg

  19. Jiménez CE, Campos VG, Castellanos PR, Romero P, Morales AE. PCR and specific antibodies to Trypanosoma cruzi in blood donors at the central blood bank from Centro Medico Nacional de Occidente (IMSS), Guadalajara, Jalisco, México. Bioquímia 2000;25:99-104.

  20. Virreira M, Torrico F, Truyens C, Alonso VC, Solano M, Carlier Y, et al. Comparison of Polymerase Chain Reaction Methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 2003;68:574-582.

  21. Dawson SB, Trapp RG. Bioestadistica médica. 2ª ed. México: Manual Moderno, 2004.

  22. Ramsey JM, Ordoñez R, Cruz CA, Alvear AL, Chavez V, Lopez R, et al. Distribution of domestic triatominae and stratification of Chagas Disease transmission in Oaxaca, Mexico. Med Vet Entomol 2000;14:19-30.

  23. Bem C, Verastegui M, Gilman RH, Lafuente C, Galdos CG, Calderon M, et al. Congenital Trypanosoma cruzi Transmission in Santa Cruz, Bolivia. Clin Infect Dis 2009;49:1667-1674. http://doi.org/bstgh8

  24. Bittencourt AL. Possible risk factors for vertical transmission of Chagas’ disease. Rev Inst Med Trop of Sau Paulo 1992;34:403-408. http:// doi.org/bm7tkx

  25. Torrico F, Alonso VC, Suarez E, Rodríguez P, Torrico MC, Dramaix M, et al. Nivel de endemia de la infección por Trypanosoma cruzi en el lugar de residencia de la madre y desarrollo de la enfermedad de Chagas congénita en Bolivia. Rev Soc Bras Med Trop 2005;38:17-20.

  26. Diez C, Manattini S, Zanuttini J, Bottasso O, Marcipar I. The value of Molecular studies for the diagnosis of congenital Chagas disease in Northeastern Argentina. Am J Trop Med Hyg 2008;78:5624-5627.

  27. Carlier Y, Truyens C. Congenital chagas disease as an ecological model of interations between Trypanosoma cruzi parasites, pregnant woman placenta and fetuses. Acta Trop 2015;151:103-115. http://doi.org/bdwp

  28. Buekens S. Congenital transmission of Trypanosoma cruzi in Argentina, Honduras and México: study protocol. Reproductive Health 2013;10:55:63.

  29. Cevallos AM, Hernández R. Chagas’ disease: pregnancy and Congenital Transmission. Biomed Res Int 2014:401864. http://doi.org/bdwq




2020     |     www.medigraphic.com